Biondi, A, Cario, G, De Lorenzo, P, Castor, A, Conter, V, Leoni, V, Gandemer, V, Pieters, R, Stary, J, Escherich, G, Campbell, M, Attarbaschi, A, Li, C-K, Vora, A, Bradtke, J, Saha, V, Valsecchi, M G & Schrappe, M 2018, ' Long-term follow-up of Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia treated with the EsPhALL2004 study : high white blood cell count at diagnosis is the strongest prognostic factor ', Haematologica . https://doi.org/10.3324/haematol.2018.199422
Haematologica Cazzaniga, G, De Lorenzo, P, Alten, J, Röttgers, S, Hancock, J, Saha, V, Castor, A, Madsen, H O, Gandemer, V, Cavé, H, Leoni, V, Köhler, R, Ferrari, G M, Bleckmann, K, Pieters, R, van der Velden, V, Stary, J, Zuna, J, Escherich, G, Stadt, U Z, Aricò, M, Conter, V, Schrappe, M, Valsecchi, M G & Biondi, A 2018, ' Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies ', Haematologica, vol. 103, no. 1, pp. 107-115 . https://doi.org/10.3324/haematol.2017.176917 Haematologica, 103(1), 107-115. Ferrata Storti Foundation